Suspected paracetamol overdose in Monrovia, Liberia: a matched case-control study.


Journal

BMC pediatrics
ISSN: 1471-2431
Titre abrégé: BMC Pediatr
Pays: England
ID NLM: 100967804

Informations de publication

Date de publication:
30 03 2020
Historique:
received: 05 04 2019
accepted: 26 02 2020
entrez: 2 4 2020
pubmed: 2 4 2020
medline: 27 2 2021
Statut: epublish

Résumé

A cluster of cases of unexplained multi-organ failure was reported in children at Bardnesville Junction Hospital (BJH), Monrovia, Liberia. Prior to admission, children's caregivers reported antibiotic, antimalarial, paracetamol, and traditional treatment consumption. Since we could not exclude a toxic aetiology, and paracetamol overdose in particular, we implemented prospective syndromic surveillance to better define the clinical characteristics of these children. To investigate risk factors, we performed a case-control study. The investigation was conducted in BJH between July 2015 and January 2016. In-hospital syndromic surveillance identified children with at least two of the following symptoms: respiratory distress with normal pulse oximetry while breathing ambient air; altered consciousness; hypoglycaemia; jaundice; and hepatomegaly. After refining the case definition to better reflect potential risk factors for hepatic dysfunction, we selected cases identified from syndromic surveillance for a matched case-control study. Cases were matched with in-hospital and community-based controls by age, sex, month of illness/admission, severity (in-hospital), and proximity of residence (community). Between July and December 2015, 77 case-patients were captured by syndromic surveillance; 68 (88%) were under three years old and 35 (46%) died during hospitalisation. Of these 77, 30 children met our case definition and were matched with 53 hospital and 48 community controls. Paracetamol was the most frequently reported medication taken by the cases and both control groups. The odds of caregivers reporting supra-therapeutic paracetamol consumption prior to admission was higher in cases compared to controls (OR 6.6, 95% CI 2.1-21.3). Plasma paracetamol concentration on day of admission was available for 19 cases and exceeded 10 μg/mL in 10/13 samples collected on day one of admission, and 4/9 (44%) collected on day two. In a context with limited diagnostic capacity, this study highlights the possibility of supratherapeutic doses of paracetamol as a factor in multi-organ failure in a cohort of children admitted to BJH. In this setting, a careful history of pre-admission paracetamol consumption may alert clinicians to the possibility of overdose, even when confirmatory laboratory analysis is unavailable. Further studies may help define additional toxicological characteristics in such contexts to improve diagnoses.

Sections du résumé

BACKGROUND
A cluster of cases of unexplained multi-organ failure was reported in children at Bardnesville Junction Hospital (BJH), Monrovia, Liberia. Prior to admission, children's caregivers reported antibiotic, antimalarial, paracetamol, and traditional treatment consumption. Since we could not exclude a toxic aetiology, and paracetamol overdose in particular, we implemented prospective syndromic surveillance to better define the clinical characteristics of these children. To investigate risk factors, we performed a case-control study.
METHODS
The investigation was conducted in BJH between July 2015 and January 2016. In-hospital syndromic surveillance identified children with at least two of the following symptoms: respiratory distress with normal pulse oximetry while breathing ambient air; altered consciousness; hypoglycaemia; jaundice; and hepatomegaly. After refining the case definition to better reflect potential risk factors for hepatic dysfunction, we selected cases identified from syndromic surveillance for a matched case-control study. Cases were matched with in-hospital and community-based controls by age, sex, month of illness/admission, severity (in-hospital), and proximity of residence (community).
RESULTS
Between July and December 2015, 77 case-patients were captured by syndromic surveillance; 68 (88%) were under three years old and 35 (46%) died during hospitalisation. Of these 77, 30 children met our case definition and were matched with 53 hospital and 48 community controls. Paracetamol was the most frequently reported medication taken by the cases and both control groups. The odds of caregivers reporting supra-therapeutic paracetamol consumption prior to admission was higher in cases compared to controls (OR 6.6, 95% CI 2.1-21.3). Plasma paracetamol concentration on day of admission was available for 19 cases and exceeded 10 μg/mL in 10/13 samples collected on day one of admission, and 4/9 (44%) collected on day two.
CONCLUSIONS
In a context with limited diagnostic capacity, this study highlights the possibility of supratherapeutic doses of paracetamol as a factor in multi-organ failure in a cohort of children admitted to BJH. In this setting, a careful history of pre-admission paracetamol consumption may alert clinicians to the possibility of overdose, even when confirmatory laboratory analysis is unavailable. Further studies may help define additional toxicological characteristics in such contexts to improve diagnoses.

Identifiants

pubmed: 32228536
doi: 10.1186/s12887-020-2008-3
pii: 10.1186/s12887-020-2008-3
pmc: PMC7104478
doi:

Substances chimiques

Analgesics, Non-Narcotic 0
Acetaminophen 362O9ITL9D

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

139

Commentaires et corrections

Type : ErratumIn

Références

PLoS Med. 2018 Feb 20;15(2):e1002508
pubmed: 29462138
N Engl J Med. 1997 Oct 16;337(16):1112-7
pubmed: 9329933
MMWR Morb Mortal Wkly Rep. 2009 Dec 11;58(48):1345-7
pubmed: 20010509
J Ethnopharmacol. 2017 Apr 18;202:154-161
pubmed: 28284793
J Gastroenterol Hepatol. 2000 Jan;15(1):9-20
pubmed: 10719741
J Pediatr. 2006 May;148(5):652-658
pubmed: 16737880
Lancet. 2008 Jan 19;371(9608):204
pubmed: 18207015
S Afr Med J. 2013 May;103(5):298-303
pubmed: 23971118
Br J Clin Pharmacol. 2016 Mar;81(3):562-8
pubmed: 26584404
Patient Educ Couns. 2015 Mar;98(3):331-7
pubmed: 25544245
J Pediatr Gastroenterol Nutr. 2017 Apr;64(4):533-535
pubmed: 27846064
Am J Ther. 2014 May-Jun;21(3):174-83
pubmed: 22407198
Liver Int. 2012 Nov;32(10):1543-56
pubmed: 22928722
Acta Paediatr. 2006 Oct;95(10):1165-71
pubmed: 16982484
J Crit Care. 2018 Feb;43:356-360
pubmed: 29132978
Hum Exp Toxicol. 2015 Jan;34(1):12-23
pubmed: 24758786
Scand J Prim Health Care. 2010 Jun;28(2):115-20
pubmed: 20470019
Curr Drug Metab. 2011 Dec;12(10):989-96
pubmed: 21892916
Mayo Clin Proc. 2014 Jan;89(1):95-106
pubmed: 24388027
BMC Pediatr. 2012 Jul 19;12:103
pubmed: 22812400
Bull World Health Organ. 2016 Sep 1;94(9):642-651
pubmed: 27708469
Br J Clin Pharmacol. 2011 Jan;71(1):20-8
pubmed: 21143497
Br J Clin Pharmacol. 2016 Oct;82(4):923-31
pubmed: 27261770
N Engl J Med. 2006 Feb 16;354(7):731-9
pubmed: 16481640
J Clin Transl Hepatol. 2014 Jun;2(2):80-94
pubmed: 26357619
Crit Care. 2015 Feb 23;19:47
pubmed: 25879892

Auteurs

Mohamad K Haidar (MK)

Epicentre, 8 Rue Saint Sabin, 75011, Paris, France. mohamadhaidar@epicentre.msf.org.
UMR 8257, Université Paris Descartes, Paris, France. mohamadhaidar@epicentre.msf.org.

Florian Vogt (F)

Epicentre, 8 Rue Saint Sabin, 75011, Paris, France.

Kensuke Takahashi (K)

Epicentre, 8 Rue Saint Sabin, 75011, Paris, France.

Fanny Henaff (F)

Médecins sans Frontières - Operational Center Paris, Paris, France.

Lisa Umphrey (L)

Médecins sans Frontières - Operational Center Paris, Paris, France.

Nikola Morton (N)

Médecins sans Frontières - Operational Center Paris, Paris, France.

Luke Bawo (L)

Ministry of Health and Social Welfare, Monrovia, Liberia.

Joseph Kerkula (J)

Ministry of Health and Social Welfare, Monrovia, Liberia.

Robin Ferner (R)

Institute of Clinical Sciences, University of Birmingham, Birmingham, England.

Klaudia Porten (K)

Epicentre, 8 Rue Saint Sabin, 75011, Paris, France.

Frederic J Baud (FJ)

Médecins sans Frontières - Operational Center Paris, Paris, France.
Assistance Publique - Hôpitaux de Paris, Paris, France.
University Paris Diderot, Paris, France.
EA7323, Evaluation of prenatal and paediatric therapeutics and pharmacology, Université Paris Descartes, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH